US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

CNS/Neurology: market research reports

RSS Feeds

CNS/Neurology market research reports and industry analysis

3  4  5  6    8    10  11  12  
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Greater China
5/19/2013 | published by: Icon Group International, Inc.
... including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as “regions”). Latent demand ...  |  read more...
$495.00
The 2013-2018 Outlook for Neurodegenerative Drugs in Greater China
5/19/2013 | published by: Icon Group International, Inc.
... Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as “regions”). Latent demand (in millions of U.S. dollars), or potential industry ...  |  read more...
$495.00
Alzheimer's Drugs Market, 2012 - 2017
5/10/2013 | published by: Roots Analysis
... the future. There is a huge unmet need in the market owing to lack of effective, disease-modifying drugs. Alzheimer’s treatment is a high risk, high reward market. Drugs currently available in the market have reached ...  |  read more...
$1,699.00
Central Nervous System Disorder Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
... China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. ...  |  read more...
$4,000.00
Mental Illness Treatment Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
... economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major ...  |  read more...
$4,000.00
Motor Neurone Diseases – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... therapeutic development for Motor Neurone Diseases, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Motor Neurone Diseases. Motor Neurone Diseases ...  |  read more...
$2,000.00
ADHD Therapeutics Market to 2018 - New Diagnostic Parameters for Adult ADHD Offer Hope for Higher Rates of Treatment
4/30/2013 | published by: GBI Research
... to 2018 - New Diagnostic Parameters for Adult ADHD Offer Hope for Higher Rates of Treatment”. The report provides insights into the up-and-coming trends of the ADHD market in seven major markets: the US, the ...  |  read more...
$3,500.00
Disruptive Behavior Disorder – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... therapeutic development for Disruptive Behavior Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Disruptive Behavior Disorder. Disruptive Behavior Disorder ...  |  read more...
$2,000.00
Tension -Type Headache Global Clinical Trials Review, H1, 2013
4/30/2013 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Tension -Type Headache. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
$2,500.00
Essential Tremor – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... for Essential Tremor, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Essential Tremor. Essential Tremor - Pipeline Review, Half Year ...  |  read more...
$2,000.00
Global Deep Brain Stimulator Market 2012-2016
4/26/2013 | published by: Infiniti Research Limited - TechNavio
... this market growth is the rapidly increasing awareness about deep brain stimulation devices in the US. The Global Deep Brain Stimulator market has also been witnessing the emergence of less invasive and non-invasive treatments. However, ...  |  read more...
$2,000.00
The Depression Market Forecast to 2021
4/25/2013 | published by: Datamonitor
... five major EU markets in 2012 Features and benefits Excel and pdf with forecasts through to 2021 covering the US, Japan, and 5 major EU markets, to allow you to assess future growth opportunities Analysis ...  |  read more...
$8,000.00
Anorexia Nervosa Global Clinical Trials Review, H1, 2013
4/22/2013 | published by: GlobalData
... and data relating to the clinical trials on Anorexia Nervosa. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...  |  read more...
$2,500.00
Dyslexia Global Clinical Trials Review, H1, 2013
4/12/2013 | published by: GlobalData
... relating to the clinical trials on Dyslexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
$2,500.00
Disease and Therapy Review: Generalized Anxiety Disorder (GAD)
4/10/2013 | published by: Timely Data Resources, Inc.
... on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the anxiety market, as well as sales of leading drugs and therapies are provided.  |  read more...
$950.00
Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H1, 2013
3/31/2013 | published by: GlobalData
... Disorder (ADHD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Attention Deficit Hyperactivity Disorder (ADHD). It includes an overview of the trial numbers and their recruitment status ...  |  read more...
$2,500.00
Biomaterials Market [By Products (Polymers, Metals, Ceramics, Natural Biomaterials) & Applications (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, Neurology Disorders)] – Global Forecasts to 2017
3/28/2013 | published by: MarketsandMarkets
... Chinese, and Aztecs used gold for dental applications. Biomaterials, which are also biocompatible, have since been adapted, improvised, and technically enabled to improve body functions and replace damaged tissues. They have evolved to include biodegradable ...  |  read more...
$4,650.00
Anorexia Nervosa – Pipeline Review, H1 2013
3/28/2013 | published by: Global Markets Direct
... for Anorexia Nervosa, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Anorexia Nervosa. Anorexia Nervosa - Pipeline Review, Half Year ...  |  read more...
$2,000.00
Brain Hemorrhage – Pipeline Review, H1 2013
3/28/2013 | published by: Global Markets Direct
... for Brain Hemorrhage, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Brain Hemorrhage. Brain Hemorrhage - Pipeline Review, Half Year ...  |  read more...
$2,000.00
2013 U.S. Patient care - Nervous system & sense organ disorders sold through Medical & surgical hospitals-Product & Services Report
3/15/2013 | published by: Barnes Reports
... The report features 2013 current and 2014 forecast estimates on the sales of Patient care - Nervous system & sense organ disorders sold through Medical & surgical hospitals nationally and for all 50 U.S. States ...  |  read more...
$199.00
2013 U.S. Patient care - Nervous system & sense organ disorders sold through Offices of physicians-Product & Services Report
3/15/2013 | published by: Barnes Reports
... report features 2013 current and 2014 forecast estimates on the sales of Patient care - Nervous system & sense organ disorders sold through Offices of physicians nationally and for all 50 U.S. States and up ...  |  read more...
$199.00
BG-12 (Multiple Sclerosis) - Forecast and Market Analysis to 2022
3/1/2013 | published by: GlobalData
... a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease management is dependent on life-long pharmacotherapy with disease-modifying therapies (DMT). ...  |  read more...
$3,495.00
Lemtrada (Multiple Sclerosis) - Forecast and Market Analysis to 2022
3/1/2013 | published by: GlobalData
... a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease management is dependent on life-long pharmacotherapy with disease-modifying therapies (DMT). ...  |  read more...
$3,495.00
Pain Management Treatment Markets
3/1/2013 | published by: TriMark Publications
... segments of the central nervous system (CNS) therapies market. Pain Management Treatment Markets focuses on the role of pain management drugs in clinical use and in drug development for acute pain, chronic pain, neuropathic path ...  |  read more...
$3,400.00
Siponimod (Multiple Sclerosis) - Forecast and Market Analysis to 2022
3/1/2013 | published by: GlobalData
... a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease management is dependent on life-long pharmacotherapy with disease-modifying therapies (DMT). ...  |  read more...
$3,495.00
3  4  5  6    8    10  11  12  
 
Our Clients